The evaluation of the effect of keishibukuryogan on blood stagnatio
Not Applicable
Recruiting
- Conditions
- blood stagnation
- Registration Number
- JPRN-UMIN000021451
- Lead Sponsor
- Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Any of the following: currently receiving a drug therapy, currently pregnant, and having and a history of anaphyraxy to keishibukuryogan.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of platelet aggregation between before, 2, 4, and 8 weeks after keishibukuryougan administration
- Secondary Outcome Measures
Name Time Method The change of platelet function between before , 2, 4, and 8 weeks after keishibukuryougan administration